This inventor holds 1 USPTO granted patent. Top assignees: ETH Zurich, Paul Scherrer Institut. Active years: 2026.
Company Filing History:
1 out of 555 
1 out of 121 
Years Active: 2026
Title: Belinda Trachsel: Innovator in Tumor and Fibrosis Diagnosis
Introduction
Belinda Trachsel is a prominent inventor based in Forschungsstrasse, Switzerland. She has made significant contributions to the field of medical diagnostics and therapy, particularly in relation to tumors and fibrosis. Her innovative work has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Belinda holds a patent titled "Conjugated Fibronectin-Binding Peptides for Use in Tumor or Fibrosis Diagnosis and Therapy." This patent represents her commitment to advancing medical science and improving patient outcomes through innovative diagnostic methods.
Career Highlights
Throughout her career, Belinda has worked with esteemed institutions such as the Paul Scherrer Institute and ETH Zurich. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Belinda has had the opportunity to work alongside notable colleagues, including Viola Vogel and Mamta Chabria. These collaborations have enriched her research and expanded the impact of her innovations.
Conclusion
Belinda Trachsel's work exemplifies the spirit of innovation in the medical field. Her contributions to tumor and fibrosis diagnosis through her patented technology highlight her dedication to improving healthcare solutions.